Options to Promote Competitive Generics Markets in the United States

JAMA. 2015 Nov 24;314(20):2129-30. doi: 10.1001/jama.2015.13498.

Authors

Clay P Wiske¹, Oluwatobi A Ogbechie², Kevin A Schulman³

Affiliations

¹ Warren Alpert Medical School of Brown University, Providence, Rhode Island2Harvard Business School, Boston, Massachusetts.
² Harvard Business School, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
³ Harvard Business School, Boston, Massachusetts4Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

PMID: 26513309
DOI: 10.1001/jama.2015.13498

No abstract available

MeSH terms

Contracts
Drug Costs*
Drugs, Generic / economics*
Drugs, Generic / supply & distribution*
Economic Competition
Economics, Pharmaceutical
Marketing / organization & administration*
United States

Substances

Drugs, Generic